Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain

Abstract Background Susceptibility of children and adults to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and persistence of antibody response to the virus after infection resolution remain poorly understood, despite their significant public health implications. Methods A prospective cross-sectional seroprevalence study with volunteer families that included at least 1 first-reported adult case positive by SARS-CoV-2 by polymerase chain reaction (PCR) and at least 1 child aged <15 years living in the same household under strict home confinement was conducted in the metropolitan Barcelona Health Region, Spain, during the pandemic period 28 April 2020–3 June 2020. All household members were tested at home using a rapid SARS-CoV-2 antibody assay with finger prick–obtained capillary blood. Results A total of 381 family households including 381 first-reported PCR-positive adult cases and 1084 contacts (672 children, 412 adults) were enrolled. SARS-CoV-2 seroprevalence rates were 17.6% (118 of 672) in children and 18.7% (77 of 335) in adult contacts (P = .64). Among first-reported cases, seropositivity rates varied from 84.0% in adults previously hospitalized and tested within 6 weeks since the first positive PCR result to 31.5% in those not hospitalized and tested after that lag time (P < .001). Nearly all (99.9%) positive children were asymptomatic or had mild symptoms. Conclusions Children appear to have similar probability as adults to become infected by SARS-CoV-2 in quarantined family households but remain largely asymptomatic. Adult antibody protection against SARS-CoV-2 seems to be weak beyond 6 weeks post-infection confirmation, especially in cases that have experienced mild disease.

[1]  Rinshu Dwivedi,et al.  The incubation period of coronavirus disease (COVID‐19): A tremendous public health threat—Forecasting from publicly available case data in India , 2021, Journal of public affairs.

[2]  Jianyun Lu,et al.  COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 , 2020, Emerging infectious diseases.

[3]  Mark S. Anderson,et al.  Test performance evaluation of SARS-CoV-2 serological assays , 2020, Nature biotechnology.

[4]  Young Joon Park,et al.  Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 , 2020, Emerging infectious diseases.

[5]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[6]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[7]  L. Fang,et al.  Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[8]  F. Zhou,et al.  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan -implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2 , 2020, medRxiv.

[9]  P. Horby,et al.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.

[10]  Ying-jian Liang,et al.  Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  David R. Holtgrave,et al.  COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State—March 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Hsien-Ho Lin,et al.  Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset , 2020, JAMA internal medicine.

[13]  H. Tian,et al.  Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China , 2020, BMJ Global Health.

[14]  Mark S. Anderson,et al.  Test performance evaluation of SARS-CoV-2 serological assays , 2020, medRxiv.

[15]  A. Vespignani,et al.  Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China , 2020, Science.

[16]  Yongsheng Wu,et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[17]  K. Tao,et al.  The characteristics of household transmission of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Kari Stefansson,et al.  Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.

[19]  Gang Wu,et al.  Household transmission of SARS-CoV-2 , 2020, Journal of Infection.

[20]  T. Skoff,et al.  Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  A. Tagarro,et al.  Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. , 2020, JAMA pediatrics.

[22]  Lauren Elisabeth Steele,et al.  Children are unlikely to have been the primary source of household SARS-CoV-2 infections , 2020, medRxiv.

[23]  Qi Jin,et al.  Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Zhongyi Jiang,et al.  Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.

[25]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[26]  Yhu-Chering Huang,et al.  Are children less susceptible to COVID-19? , 2020, Journal of Microbiology, Immunology and Infection.

[27]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[28]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[29]  T. Burki Coronavirus in China , 2020, The Lancet Respiratory Medicine.

[30]  Don Klinkenberg,et al.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[32]  W. Cao,et al.  Disappearance of antibodies to SARS-associated coronavirus after recovery. , 2007, The New England journal of medicine.

[33]  World Health Organization,et al.  Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .